Design and evaluation of a pharmacogenomics information resource for pharmacists

  title={Design and evaluation of a pharmacogenomics information resource for pharmacists},
  author={Katrina M. Romagnoli and Richard David Boyce and Philip E. Empey and Yifan Ning and Solomon M. Adams and Harry Hochheiser},
  journal={Journal of the American Medical Informatics Association},
Objective To develop and evaluate a pharmacogenomics information resource for pharmacists. Materials and Methods We built a pharmacogenomics information resource presenting Food and Drug Administration (FDA) drug product labelling information, refined it based on feedback from pharmacists, and conducted a comparative usability evaluation, measuring task completion time, task correctness and perceived usability. Tasks involved hypothetical clinical situations requiring interpretation of… 
5 Citations

Figures and Tables from this paper

Opinion, experience and educational preferences concerning pharmacogenomics: an exploratory study of Quebec pharmacists.
Identifying the educational preferences of pharmacists may help in the development of educational programs to help them integrate pharmacogenomics in their clinical practice.
A Pharmacogenomics Clinical Decision Support Service Based on FHIR and CDS Hooks.
This work sought to develop a PGx clinical decision support service, leveraging the emerging FHIR and CDS Hooks standards, and based on an assumption that pharmacogene sequencing data would be stored alongside the EHR in a GACS.
Review of Present Trends and Future Scope of Pharmacogenomics in Drug Discovery and Development Process
Critical aspects of drug developments, clinical trial design and ethical issues which are centered with pharmacogenomics are provided.
Pharmacogenomics courses in pharmacy school curricula.
While many pharmacy schools have responded to the accreditation standards to include PGx, less than half of the schools have developed a standalone course.


Integrating pharmacogenomics into pharmacy practice via medication therapy management.
  • Susan M. Reiss
  • Medicine, Political Science
    Journal of the American Pharmacists Association : JAPhA
  • 2011
The pharmacy profession must define a process for the application of pharmacogenomic data into pharmacy clinical practice that is aligned with MTM service delivery, develop a viable business model for these practices, and encourage and direct the development of HIT solutions that support the pharmacist's role in this emerging field.
Assessment of the Pharmacogenomics Educational Needs of Pharmacists
A large, academic, multi-campus healthcare system, large-scale study of inpatient and outpatient pharmacists in applying pharmacogenomics information to clinical practice found that pharmacists lack the knowledge and self-confidence to act on the results of Pharmacogenomics testing.
Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties
Educational resources that are clinically oriented and easily accessible are preferred by physicians, and may best support appropriate clinical implementation of pharmacogenomics.
An evaluation of pharmacists' expectations towards pharmacogenomics.
A survey of 284 pharmacists practicing in the province of Québec to describe the opinions, expectations and concerns of pharmacists toward pharmacogenomics found Pharmacists are extremely hopeful towards pharmacogenomic testing and the vast majority is willing to integrate these tests as part of their clinical practice.
PharmGKB: a logical home for knowledge relating genotype to drug response phenotype
The success of GenBank and the suite of NCBI data resources has demonstrated clearly that the NCBI is capable of meeting the demand for high volumes of raw data and serving as a reliable repository.
Table of Pharmacogenomic Biomarkers in Drug Labeling
  • Biology, Medicine
  • 2015
The labeling for some, but not all, of the products includes specific actions to be taken based on the biomarker information, and Pharmacogenomic information can appear in different sections of the labeling depending on the actions.
Toward semantic modeling of pharmacogenomic knowledge for clinical and translational decision support
A semantic model of the pharmacogenomics information found in drug product labels showed the potential to make the unstructured pharmacogenomic information currently written in product labeling more accessible and actionable through structured annotations of Pharmacogenomics effects and clinical recommendations.